Drug interaction study tests safety of combining itraconazole with BI 1815368
NCT ID NCT05965583
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 trial studied 14 healthy men to see if taking itraconazole (an antifungal) changes how the body absorbs an experimental drug called BI 1815368. Participants received BI 1815368 alone and then again with itraconazole. The goal was to measure drug levels in the blood to guide future dosing recommendations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BI 1815368 and itraconazole
What this could lead to
If successful, this study will help determine safe dosing of BI 1815368 when taken with itraconazole, supporting future trials in patients.
What could go wrong
This is a small, early-stage drug interaction study in healthy volunteers, not patients. Results may not predict effects in sicker populations or with long-term use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany